ETRA

Electra Therapeutics, Inc.

Nasdaq· CIK 0002088082 Biotech & Drug Discovery

$8.37 −0.34 (−3.90%)

Oct 26 4:00 PM ET · prev $8.71

Market cap

$580.6M

Small cap

Median target

🔒 Subscribers only

Since first trade

−36.8%

from $13.25 · Sep 18

30 days

−26.1%

from $11.32

Range since listing

$8.37–13.92

at the low

Avg volume 20D

494.6K

Oct 16 spike 1.38M

Short interest

702.3K

≈1.1% of shares

Days to cover

1.0

at average volume

Insider net

+$40.0M

2 buyers · 0 sellers · 12 mo

Filing reports

analyzed by SecBot

SecBot read BULLISH 12 reports · 90 days

Balance 0 bearish · 4 bullish · 8 neutral oldest → newest, height = score

Avg score

·High conf. 12/12

Strongest BULLISH Electra Therapeutics priced its IPO of 23,333,334 shares at $15.00 per share, raising $350.0 million in…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

E Sep 18 Offering: Electra Therapeutics Announces Pricing of Upsized $350.0 M…
R Sep 18 Electra Therapeutics priced its IPO of 23,333,334 shares at $15.00 p…
R Sep 18 Electra Therapeutics' S-1 registration statement for its IPO of comm…
R Sep 18 Electra Therapeutics priced its upsized IPO of 23,333,334 shares at…
B Sep 21 2 insiders buy $40.0M at $15.00
R Sep 23 OrbiMed Advisors LLC and Carl L. Gordon, both directors and 10% owne…
A Oct 13 4 analysts initiate
A Oct 23 HC Wainwright & Co. initiates

Signal stack

Where each data set points today.

InsidersBULLISH

2 insiders bought $40.0M at an average $15.00. No open-market sales. Price is 44% below their cost.

The Street

last action Oct 2026

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access

Recent actions

Date	Firm	Action	Rating
Oct 23, 2026	HC Wainwright & Co. INITIATE	INITIATE	Buy
Oct 22, 2026	JP Morgan INITIATE	INITIATE	Overweight
Oct 13, 2026	Jefferies INITIATE	INITIATE	Buy
Oct 13, 2026	Evercore ISI Group INITIATE	INITIATE	Outperform
Oct 13, 2026	TD Cowen INITIATE	INITIATE	Buy
Oct 13, 2026	Cantor Fitzgerald INITIATE	INITIATE	Overweight

Catalysts

Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.

Recent

Sep 18, 2026

Listing

New Listing: ETRA — Electra Therapeutics, Inc. - Common stock

Listed on exchange Q

Sep 17, 2026

Offering

Electra Therapeutics Announces Pricing of Upsized $350.0 Million Initial Public Offering

SOUTH SAN FRANCISCO, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Electra Therapeutics, Inc., a late clinical-stage biopharmaceutical company focused…

Insider ledger

Form 4

$40.0M

bought · 2 insiders

sold · 0 insiders

−44.2%

vs their $15.00 cost

Date	Insider	Type	Value
Sep 21, 2026	Dong Quehuong (Kathy) President & CEO	CONVERT	455,484 sh
Sep 21, 2026	Dong Quehuong (Kathy) President & CEO	CONVERT	455,484 sh
Sep 21, 2026	Parry Graham Chief Scientific Officer	CONVERT	85,504 sh
Sep 21, 2026	Parry Graham Chief Scientific Officer	CONVERT	85,504 sh
Sep 21, 2026	Stagliano Nancy Director	CONVERT	255,635 sh
Sep 21, 2026	Stagliano Nancy Director	CONVERT	255,635 sh
Sep 21, 2026	Koe Gary S. Chief Technical Officer	CONVERT	63,656 sh
Sep 21, 2026	Koe Gary S. Chief Technical Officer	CONVERT	63,656 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

Period	EPS est.	Range	30D rev.	Revenue
Current Q	🔒 Fresh data, subscribers only
Next Q	🔒 Fresh data, subscribers only
Current FY	🔒 Fresh data, subscribers only
Next FY	🔒 Fresh data, subscribers only